Insider Selling: Organigram Holdings Inc. (TSE:OGI) Senior Officer Sells C$35,140.90 in Stock

Organigram Holdings Inc. (TSE:OGIGet Free Report) Senior Officer Paolo De Luca sold 13,835 shares of the business’s stock in a transaction that occurred on Wednesday, September 11th. The shares were sold at an average price of C$2.54, for a total value of C$35,140.90. Following the completion of the sale, the insider now owns 625 shares of the company’s stock, valued at approximately C$1,587.50.

Paolo De Luca also recently made the following trade(s):

  • On Friday, August 16th, Paolo De Luca sold 10,266 shares of Organigram stock. The stock was sold at an average price of C$2.76, for a total transaction of C$28,334.16.

Organigram Trading Up 1.2 %

OGI opened at C$2.52 on Monday. Organigram Holdings Inc. has a one year low of C$1.35 and a one year high of C$3.95. The company has a debt-to-equity ratio of 1.13, a current ratio of 6.95 and a quick ratio of 2.62. The business has a 50 day simple moving average of C$2.37 and a two-hundred day simple moving average of C$2.51. The firm has a market capitalization of C$273.60 million, a price-to-earnings ratio of -1.00, a PEG ratio of 0.42 and a beta of 1.13.

Organigram (TSE:OGIGet Free Report) last posted its earnings results on Tuesday, August 13th. The company reported C$0.03 earnings per share (EPS) for the quarter, beating the consensus estimate of C($0.07) by C$0.10. Organigram had a negative return on equity of 54.53% and a negative net margin of 153.80%. The firm had revenue of C$41.06 million for the quarter, compared to analysts’ expectations of C$39.20 million. Analysts predict that Organigram Holdings Inc. will post 0.1735254 EPS for the current year.

Analyst Ratings Changes

Separately, Canaccord Genuity Group increased their price target on shares of Organigram from C$3.25 to C$3.60 and gave the company a “speculative buy” rating in a research report on Wednesday, August 14th.

Get Our Latest Research Report on Organigram

About Organigram

(Get Free Report)

Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O’ Buds, Monjour, Trailblazer, SHRED’ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.

Featured Articles

Receive News & Ratings for Organigram Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organigram and related companies with MarketBeat.com's FREE daily email newsletter.